PreprintAll rights reservedmedRxiv
Anticholinergic Co-Medication Burden Does Not Predict Cardiac Toxicity in Adolescent Diphenhydramine Exposure: A Pharmacovigilance Study of the FDA Adverse Event Monitoring System
- 1Youreka Toronto
Related
- A Diphenhydramine Overdose Mimicking Encephalitis, Complicated by Acute Kidney Injury Associated with Anticholinergic Urinary Retention: A Case Report
- Predictors and prescribing patterns of definite anticholinergic medication use among community-dwelling older adults in Saudi Arabia: a retrospective multicenter cross-sectional study
- Statistical process control within the Six Sigma DMAIC framework for monitoring medication dispensing errors in hospital pharmacies: a Saudi case study
- Tripelennamine 1% topical cream versus diphenhydramine 1% topical cream for the relief of histamine-induced itching: A proof-of-concept study in healthy adults.
- The clinical value of routine biannual monitoring in primary care in ADHD medication users
BibTeX
@misc{dong2026anticholinergic,
title = {{Anticholinergic Co-Medication Burden Does Not Predict Cardiac Toxicity in Adolescent Diphenhydramine Exposure: A Pharmacovigilance Study of the FDA Adverse Event Monitoring System}},
author = {Z. Dong and N. Fadel and S. Krishnan and P. Cai},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.11.26365234},
url = {https://www.medrxiv.org/content/10.64898/2026.10.11.26365234v1},
}
RIS
TY - UNPB
TI - Anticholinergic Co-Medication Burden Does Not Predict Cardiac Toxicity in Adolescent Diphenhydramine Exposure: A Pharmacovigilance Study of the FDA Adverse Event Monitoring System
AU - Z. Dong
AU - N. Fadel
AU - S. Krishnan
AU - P. Cai
PY - 2026
DA - 2026/10/11
PB - medRxiv
DO - 10.64898/2026.10.11.26365234
UR - https://www.medrxiv.org/content/10.64898/2026.10.11.26365234v1
ER -